Investor profile
Sebastian Huayamares
Private equity, Venture capital, Venture debt & Healthcare Associate at RA Capital Management, Biotech Investor at General Atlantic
Sebastian Huayamares is a Biotech Investor at General Atlantic, whose known portfolio counts 19 companies.
Is Sebastian Huayamares a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIFinTechHealthcareSaaS
Contacts
Affiliated funds' portfolios
Healthcare Associate at RA Capital Management, whose known portfolio counts 10 companies
- ADCendo
- Terremoto Biosciences
- OnKure Therapeutics
- Pinnacle Medicines
- Climb Bio
- Stipple Bio
- Altimmune
- Terrestrial Bio
- Zai Lab
- Prelude Therapeutics
Biotech Investor at General Atlantic, whose known portfolio counts 19 companies
- Runway
- Allonnia
- SmartHR
- Port
- Sierra Space
- Citibanamex
- Odoo
- 80 Acres Farms
- Brevo
- Frazier & Deeter
- Hostaway
- Nerdio
- and 7 more
Investor Profile
The listing covers sectors AI, FinTech, Healthcare and SaaS, and focus areas Banking, Biotech, Clinical-stage and Cloud Infrastructure. Startups operating in these areas may find Sebastian Huayamares relevant.
Stage-wise, the deals at General Atlantic cluster around Growth, Late-Stage and Series A rounds.
The firm portfolio and the focus above give founders context on whether Sebastian Huayamares matches their raise.
Colleagues
Showing 20 of 90
Shantanu Rastogi
Managing Director
Mumbai, India
Robbert Vorhoff
Managing Director
New Orleans, United States
Peter Kolchinsky
Managing Partner
Boston, United States
Jenna Hebert
Investment Director
Boston, United States
Derek DiRocco
Partner
Boston, United States
Anurag Kondapalli
Principal
New York, United States
Rebecca Silberman
Investment Director
Cambridge, United States
Daniel Bahcheli
Director
Boston, United States
Matthew Hammond
Partner
Boston, United States
Aaron Goldman
Managing Director
New York, United States
Vinay Trivedi
Investment Team
New York, United States
Raph Osnoss
Managing Director
New York, United States
Shan Shan Wang
Associate Director
Boston, United States
Anish Batlaw
Managing Director
Miami Beach, United States
Zach Scheiner
Partner
San Francisco, United States
Laura Chen
Vice President
New York, United States
Tyler Carney
Investor
New York, United States
Brett Zbar
Global Head of Life Sciences
New York, United States
Paul Stamas
Managing Director
New York, United States
Ross Chikarmane
Biotech company builder, investor, scientist
Boston, United States
Frequently asked questions
Who is Sebastian Huayamares?
Sebastian Huayamares is a private equity investor and venture capital investor based in New York City, United States, listed as Biotech Investor at General Atlantic. The known portfolio of that firm counts 19 companies. That portfolio belongs to the firm, not to Sebastian Huayamares personally.
What does Sebastian Huayamares invest in?
Listed sectors include AI, FinTech, Healthcare and SaaS; listed focus areas include Banking, Biotech, Clinical-stage and Cloud Infrastructure. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Sebastian Huayamares invest at?
General Atlantic appears in Growth, Late-Stage and Series A rounds across its known deals, and Sebastian Huayamares is listed there as Biotech Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Sebastian Huayamares listed at?
Sebastian Huayamares is listed as Biotech Investor at General Atlantic. 90 other people in the database share a firm with Sebastian Huayamares.
How do I contact Sebastian Huayamares?
A LinkedIn page is on file for Sebastian Huayamares. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal